/> ShareJunction - Member Posts
logo transparent gif
top_white_spacer
Home Latest Stock Forum Topics MyCorner - Personal Stocks Porfolio Stock Lists Investor Insights Investor Research & Links Dynamic Stock Charting FREE Registration About Us top spacer top spacer
 User Password Auto-Login
Enter Stock
 
righttip
branding

Back

Latest Posts By RODSTEWARD - Member      About RODSTEWARD
First   < Newer   601-620 of 688   Older>   Last  

28-Apr-2026 10:54 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		Looks weak today n EGM coming n market dont like giving out 1,012,322 free shares to ceo again upon EGM
Good Post  Bad Post 
28-Apr-2026 09:29 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		hope it will clear 0.43 first...

piscesmonkey      ( Date: 28-Apr-2026 09:16) Posted:

After many days of accumulating today should be more up above 40cents?
Good Post  Bad Post 
28-Apr-2026 09:16 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		After many days of accumulating today should be more up above 40cents?
Good Post  Bad Post 
27-Apr-2026 16:29 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		Time will tell.
In the meantime, to each, his own.
No one knows at this time how it is going to turn out.
 
Good Post  Bad Post 
27-Apr-2026 16:21 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 1 		After donkey years only started to moves up recently.
Have to wait another cycle of donkey years to come for another excitement.
In the meantime, will continue to Lao Sai everyday.
Good Post  Bad Post 
27-Apr-2026 14:50 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		Typically, it will take a couple of years to get FDA approval - deoneding also on how fast cllinical trial can be completed.
IX BiPharma' s sublingual painkiller is already at Phase 3.
Also in IX BioPharma case, the EUA allows usage first.
Think the commercialisation  will be fast-track.

Also the funding from US DoD means that is little to no risk at all.

One huge potential is the buying out/taking over by bigger pharma companies.

JAMMIE      ( Date: 27-Apr-2026 14:32) Posted:

Atleast 2-3 years away. The FDA approval itself is set for 2028 if I am not mistaken.  so a long way to go. The recent run up in price was because of the analysts giving a TP of $1 and the recent funding that came from US Govt. There is defninite potential but for the long term. Because it has climbed up very quickly any entry point right now is quite a risk. Shouldideally want atleast 2 qrts and follow the mngt commentary before deciding tio lock money for the long term in this one. 

Sgvale      ( Date: 27-Apr-2026 13:31) Posted:

Will this go for US listing since US defence set its interest.?
Good Post  Bad Post 
27-Apr-2026 14:32 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		Atleast 2-3 years away. The FDA approval itself is set for 2028 if I am not mistaken.  so a long way to go. The recent run up in price was because of the analysts giving a TP of $1 and the recent funding that came from US Govt. There is defninite potential but for the long term. Because it has climbed up very quickly any entry point right now is quite a risk. Shouldideally want atleast 2 qrts and follow the mngt commentary before deciding tio lock money for the long term in this one. 

Sgvale      ( Date: 27-Apr-2026 13:31) Posted:

Will this go for US listing since US defence set its interest.?
Good Post  Bad Post 
27-Apr-2026 14:26 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		Fake rise so far, the real bbs have not come out to play yet?
Good Post  Bad Post 
27-Apr-2026 13:31 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		Will this go for US listing since US defence set its interest.?
Good Post  Bad Post 
27-Apr-2026 11:40 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 1 		Today got power
Good Post  Bad Post 
24-Apr-2026 17:49 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		It is $2+ after 2 for 1 bonus issue.
Original investor before the bonus issue would
have earned a value o about $7.

JAMMIE      ( Date: 24-Apr-2026 15:08) Posted:

Its all in the details. You need to do your own due diligence.  The main catalyst is the FDA approval and thats somewhere in 2027-2028. So you have to factor that do they have the money to keep going for next 2-3 years, will they need to raise money again etc etc. the analysts have given a target price of SGD 1.00 but there is no time period defined. Maybe eventually it wil lreach there. Look at Oiltek, it listed at around 11c and now is $2.00+ in about 3 years. 
 

Sgvale      ( Date: 24-Apr-2026 14:42) Posted:

Is the Co. finance and prospect better compared to last time it listed at 0.46?


Good Post  Bad Post 
24-Apr-2026 15:08 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		Its all in the details. You need to do your own due diligence.  The main catalyst is the FDA approval and thats somewhere in 2027-2028. So you have to factor that do they have the money to keep going for next 2-3 years, will they need to raise money again etc etc. the analysts have given a target price of SGD 1.00 but there is no time period defined. Maybe eventually it wil lreach there. Look at Oiltek, it listed at around 11c and now is $2.00+ in about 3 years. 
 

Sgvale      ( Date: 24-Apr-2026 14:42) Posted:

Is the Co. finance and prospect better compared to last time it listed at 0.46?

JAMMIE      ( Date: 24-Apr-2026 13:29) Posted:

u can get all this info from AI. 
 
At its July 2015 initial public offering (IPO) on the Singapore Exchange (SGX) Catalist board,  iX Biopharma Ltd.  listed at a price of  S$0.46 per share. 
The Straits TimesThe Straits Times  +1
The company offered a total of  65.5 million new shares  during its debut. This offering was broken down into two tranches: 
The Business TimesThe Business Times  +1
  • Placement shares:  64.5 million shares were allocated to institutional and other investors.
  • Public subscription:  1.0 million shares were made available to the general public.
Since its IPO in July 2015, ordinary shareholders of iX Biopharma have experienced significant dilution, with the total number of issued shares increasing by approximately  78%. 
  • IPO Share Count (July 2015):  The company listed with an enlarged share capital of  ~589 million shares.
  • Current Share Count (April 2026):  Following the exercise of warrants and various placements, the total issued shares reached  1,048,324,529
Impact on Shareholder Ownership
If you held 1% of the company at IPO (approx. 5.89 million shares), your ownership would have dropped to roughly  0.56%  today if you did not participate in subsequent rights issues or placements.
Despite this dilution, the  Singapore Exchange  (SGX) and  Yahoo Finance  reports show that the share price recently recovered to its IPO level of  S$0.46  in April 2026, driven by a  US$40.95 million  contract from the US Department of Defense.
Good Post  Bad Post 
24-Apr-2026 14:42 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		Is the Co. finance and prospect better compared to last time it listed at 0.46?

JAMMIE      ( Date: 24-Apr-2026 13:29) Posted:

u can get all this info from AI. 
 
At its July 2015 initial public offering (IPO) on the Singapore Exchange (SGX) Catalist board,  iX Biopharma Ltd.  listed at a price of  S$0.46 per share. 
The Straits TimesThe Straits Times  +1
The company offered a total of  65.5 million new shares  during its debut. This offering was broken down into two tranches: 
The Business TimesThe Business Times  +1
  • Placement shares:  64.5 million shares were allocated to institutional and other investors.
  • Public subscription:  1.0 million shares were made available to the general public.
Since its IPO in July 2015, ordinary shareholders of iX Biopharma have experienced significant dilution, with the total number of issued shares increasing by approximately  78%. 
  • IPO Share Count (July 2015):  The company listed with an enlarged share capital of  ~589 million shares.
  • Current Share Count (April 2026):  Following the exercise of warrants and various placements, the total issued shares reached  1,048,324,529
Impact on Shareholder Ownership
If you held 1% of the company at IPO (approx. 5.89 million shares), your ownership would have dropped to roughly  0.56%  today if you did not participate in subsequent rights issues or placements.
Despite this dilution, the  Singapore Exchange  (SGX) and  Yahoo Finance  reports show that the share price recently recovered to its IPO level of  S$0.46  in April 2026, driven by a  US$40.95 million  contract from the US Department of Defense.


Sgvale      ( Date: 24-Apr-2026 13:12) Posted:

What's the ipo price?
Good Post  Bad Post 
24-Apr-2026 13:29 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		u can get all this info from AI. 
 
At its July 2015 initial public offering (IPO) on the Singapore Exchange (SGX) Catalist board,  iX Biopharma Ltd.  listed at a price of  S$0.46 per share. 
The Straits TimesThe Straits Times  +1
The company offered a total of  65.5 million new shares  during its debut. This offering was broken down into two tranches: 
The Business TimesThe Business Times  +1
  • Placement shares:  64.5 million shares were allocated to institutional and other investors.
  • Public subscription:  1.0 million shares were made available to the general public.
Since its IPO in July 2015, ordinary shareholders of iX Biopharma have experienced significant dilution, with the total number of issued shares increasing by approximately  78%. 
  • IPO Share Count (July 2015):  The company listed with an enlarged share capital of  ~589 million shares.
  • Current Share Count (April 2026):  Following the exercise of warrants and various placements, the total issued shares reached  1,048,324,529
Impact on Shareholder Ownership
If you held 1% of the company at IPO (approx. 5.89 million shares), your ownership would have dropped to roughly  0.56%  today if you did not participate in subsequent rights issues or placements.
Despite this dilution, the  Singapore Exchange  (SGX) and  Yahoo Finance  reports show that the share price recently recovered to its IPO level of  S$0.46  in April 2026, driven by a  US$40.95 million  contract from the US Department of Defense.


Sgvale      ( Date: 24-Apr-2026 13:12) Posted:

What's the ipo price?

RODSTEWARD      ( Date: 24-Apr-2026 10:31) Posted:

Keep issue shares n diluting how to go up n interest drying out after waiting 11 years never hit above IPO price what a shame n still give performane free shares
Good Post  Bad Post 
24-Apr-2026 13:12 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		What's the ipo price?

RODSTEWARD      ( Date: 24-Apr-2026 10:31) Posted:

Keep issue shares n diluting how to go up n interest drying out after waiting 11 years never hit above IPO price what a shame n still give performane free shares
Good Post  Bad Post 
24-Apr-2026 13:03 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		Saw some movement in this stock
Good Post  Bad Post 
24-Apr-2026 10:31 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		Keep issue shares n diluting how to go up n interest drying out after waiting 11 years never hit above IPO price what a shame n still give performane free shares
Good Post  Bad Post 
24-Apr-2026 10:19 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 1 		sell in may and go ago is arriving soon

parcvista      ( Date: 24-Apr-2026 10:19) Posted:

Mum pretty quiet here today
Good Post  Bad Post 
24-Apr-2026 10:19 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		Mum pretty quiet here today
Good Post  Bad Post 
24-Apr-2026 08:27 IX Biopharma   /   iX Biopharma       Go to Message
x 0
x 0 		iX Biopharma (SGX:42C) allotted and issued nearly 1.2 million shares at SG$0.06 per share, pursuant to the exercise of warrants, according to a Thursday filing with the Singapore Exchange. Following the issue, the company's share capital increased to close to 1.05 billion shares, with the new shares expected to be listed and quoted on or around April 27.
Good Post  Bad Post 
First   < Newer   601-620 of 688   Older>   Last  



ShareJunction Version: 27 Nov 2020 ver - All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright © SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux. Hosted with Signetique Cloud.